About

Log in?

DTU users get better search results including licensed content and discounts on order fees.

Anyone can log in and get personalized features such as favorites, tags and feeds.

Log in as DTU user Log in as non-DTU user No thanks

DTU Findit

Journal article

SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation

From

Department of Medical Genetics, Peking University Health Science Center, Beijing, China.1

Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark.2

Department of Gastroenterological Surgery, Peking University People's Hospital, Beijing, China.3

Department of Biochemistry and Molecular Biology, Shenzhen University School of Medicine, Shenzhen, China.4

Institute of Systems Biomedicine, Peking University Health Science Center, Beijing, China.5

Institute for Cancer Genetics, Columbia University, New York, New York.6

Department of Medical Genetics, Peking University Health Science Center, Beijing, China. luojianyuan@bjmu.edu.cn.7

Department of Medical & Research Technology, School of Medicine, University of Maryland, Baltimore, Maryland.8

The mitochondrial serine hydroxymethyltransferase SHMT2, which catalyzes the rate-limiting step in serine catabolism, drives cancer cell proliferation, but how this role is regulated is undefined. Here, we report that the sirtuin SIRT5 desuccinylates SHMT2 to increase its activity and drive serine catabolism in tumor cells.

SIRT5 interaction directly mediated desuccinylation of lysine 280 on SHMT2, which was crucial for activating its enzymatic activity. Conversely, hypersuccinylation of SHMT2 at lysine 280 was sufficient to inhibit its enzymatic activity and downregulate tumor cell growth in vitro and in vivo Notably, SIRT5 inactivation led to SHMT2 enzymatic downregulation and to abrogated cell growth under metabolic stress.

Our results reveal that SHMT2 desuccinylation is a pivotal signal in cancer cells to adapt serine metabolic processes for rapid growth, and they highlight SIRT5 as a candidate target for suppressing serine catabolism as a strategy to block tumor growth.Significance: These findings reveal a novel mechanism for controlling cancer cell proliferation by blocking serine catabolism, as a general strategy to impede tumor growth.

Cancer Res; 78(2); 372-86. ©2017 AACR.

Language: English
Publisher: American Association for Cancer Research
Year: 2018
Pages: 372-386
ISSN: 15387445 and 00085472
Types: Journal article
DOI: 10.1158/0008-5472.CAN-17-1912

DTU users get better search results including licensed content and discounts on order fees.

Log in as DTU user

Access

Analysis